Donate now
EN FR
Content

Cervical cancer

Introduction
Summary
In 2022, an estimated 660 000 women were diagnosed with cervical cancer worldwide and about 350 000 women died from the disease. The main cause of cervical cancer is persistent infection with high-risk types of human papillomavirus (HPV), an extremely common family of viruses that are transmitted through sexual contact. Vaccines exist that protect against high-risk HPV types, and screening programmes can detect signs of disease at an early stage, allowing for effective treatment and management of the condition. This means that cervical cancer should be one of the most preventable and treatable forms of cancer. In many high-income countries, this is the case. High incidence rates and high mortality rates of cervical cancer occur mainly (~90% for both) in low- and middle-income countries.
News & Events
News & Events
Press Releases
Press Releases
Press Release

New research highlights the potential of single-dose HPV vaccination to advance cervical cancer prevention in low-resource settings

Go to PDF 13.11.2024
Highlights
Highlights
Featured News

Cancer Screening in Five Continents (CanScreen5): a global data repository for breast, cervical, and colorectal cancer screening programmes

Read More 30.04.2024
Videos
Videos
Infographics
Infographics
Q&As
Q&As
Research Project Websites
Research Project Websites
This page shows selected content only. For more information, please use the search function.
Close Reading Mode
UP